The eight genes where higher expression was associated with worse prognosis (CYC, CYP51A1, DHFR, EBP, KIF15, PPM1D, SQLE, and UMPS) represent potential additional therapeutic targets in metastatic prostate cancer. This evidence concerns the gene KIF15 and metastatic prostate carcinoma.